EXCLUSIVE Archives - PharmaShots

EXCLUSIVE

Exclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight

Shots: Given the high variability and subjectivity of traditional clinical scales, there is an urgent need for objective biomarkers to assess CNS disease progression more reliably NeuraLight is at the forefront of precision neurology, developing objective and sensitive biomarkers that bring greater accuracy and consistency to CNS research In this exclusive conversation, Edmund…

October 14, 2025

Exclusive Interview_Dr. Mónica Domínguez_2025

Exclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind

Shots: Smile Train is a proud partner of the FDI World Dental Federation's annual World Oral Health Day Campaign, which is focusing this year on the theme "A Happy Mouth is a Happy Mind" to promote the importance of oral health and mental health Through this campaign, Smile Train's goal is to educate the world…

March 20, 2025

Exclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots

Highlights: Systemic mastocytosis (SM) is a rare disease caused by the abnormal accumulation of mast cells – a key part of the body’s immune systemPeople with SM face potentially debilitating symptoms, such as skin lesions, diarrhoea, bone pain, fatigue and anaphylaxis, which can present challenges across various aspects of patients’ livesFor more than…

March 12, 2025

Exclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots

Shots:Integrating innovation with the scientific principles of Ayurveda, AIMIL Pharmaceuticals caters to the growing needs of healthcare professionals, patients, and the animal healthcare sectorPharmaShots welcomes Dr. Ikshit Sharma, Director at AIMIL Pharmaceuticals, in a riveting conversation. Ikshit stresses the significance of making investments in research and development for creating novel therapies and addressing…

January 20, 2025

Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots

Shots: Arcellx’s Anito-cel, a BCMA CAR-T therapy recently got the FTD, ODD, RMAT designations by the FDA for the treatment of patients with relapsed or refractory multiple myeloma (r/rMM) Today, at PharmaShots we have Chris Heery, Chief Medical Officer at Arcellx, shedding light on Anito-Cel therapy in advancing care for multiple myeloma In late 2022,…

September 30, 2024

Exclusive_Moitreyee Chatterjee-Kishore_2024

Decoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots

Shots: Recently EC granted Marketing Authorization to Astellas’ VYLOY (zolbetuximab) in combination with chemotherapy for the treatment of patients with advanced gastric and GEJ cancers Zolbetuximab, a monoclonal antibody designed to target gastric tumor cells that express CLDN18.2 biomarker Today, at PharmaShots we have Dr. Moitreyee Chatterjee-Kishore the Head of Development, Immuno-Oncology and Cancer Cell…

September 26, 2024

Advancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots

Shots: Recently, the CHMP of the EMA adopted a positive opinion for Astellas’ Padcev + Keytruda combination therapy as the first-line treatment of patients with unresectable or metastatic urothelial cancer Today, in an exclusive coverage, we bring an enlightening conversation with Ahsan Arozullah from Astellas Pharma, sharing insights from the P-III EV-302 study Astellas looks…

September 4, 2024

Exclusive: David Esposito in an Illuminating Discussion with PharmaShots

Shots: Our recent Spotlight interview with David Esposito, CEO at ONL therapeutics became a major hit on the internet. We were moved by the overwhelming response from the netizens Here we have again, David Esposito in an engaging conversation with PharmaShots. David discusses in great length about the company’s lead candidate ONL1204, currently being evaluated…

March 12, 2024

Exclusive: GeoVax’s CEO David A. Dodd in an Engaging Conversation with PharmaShots

Shots: In an extended cut to our Spotlight Interview, PharmaShots presents an exclusive interview session with David A. Dodd, Chairman, President, and CEO at GeoVax labs David speaks about the company’s rich history and highlights the journey through the years and the strategic shift from being a single-focus HIV vaccine developing company to an infectious…

March 6, 2024

Noelle Bush in an Enlightening Interview with PharmaShots Shares Insights from the It Takes 2 Awareness Program

Shots: Exemplifying awareness campaign at its best with a hint of contemporary music, “It takes 2” by Boehringer Ingelheim and Eli Lilly is a noble initiative aimed at integrating UACR testing with eGFR for better screening of CKD Noelle Bush, in an engaging conversation with PharmaShots, cites the growing incidences of CKD in the US.…

January 15, 2024